A High-Sensitivity Colorimetric Dot-Blot Aptamer Assay Platform for SARS-CoV-2 Nucleocapsid Protein Detection in Resource-Limited Settings
ACS Infectious Diseases · 10.07.2026 · 12 (7) · 2251-2261
DOI: 10.1021/acsinfecdis.5c01125 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 05.06.2026. Verfasst von Kauser Banu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, RVCE, Mysore Rd, RV Vidyaniketan, Post, Bengaluru, Karnataka 560059, India. Hauptthemen laut MEDLINE: SARS-CoV-2, Aptamers, Nucleotide, Colorimetry, COVID-19. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, RVCE, Mysore Rd, RV Vidyaniketan, Post, Bengaluru, Karnataka 560059, India.
- Shankaranarayana Life Sciences LLP, 144-C/1, Kirloskar Road, Bommasandra Industrial Estate, Hebbagodi, Bengaluru, Karnataka 560100, India.
ORCID-Profile: Kauser Banu, Bhairab Mondal, C Sai Sudha, Raju H
Zitieren
APA
Banu, K., Mondal, B., Kumar, S. M., Sudha, C. S., & H, R. (2026). A High-Sensitivity Colorimetric Dot-Blot Aptamer Assay Platform for SARS-CoV-2 Nucleocapsid Protein Detection in Resource-Limited Settings. ACS Infectious Diseases, 12(7), 2251-2261. https://doi.org/10.1021/acsinfecdis.5c01125
Vancouver
Banu K, Mondal B, Kumar SM, Sudha CS, H R. A High-Sensitivity Colorimetric Dot-Blot Aptamer Assay Platform for SARS-CoV-2 Nucleocapsid Protein Detection in Resource-Limited Settings. ACS Infectious Diseases. 2026;12(7):2251-2261. doi:10.1021/acsinfecdis.5c01125
BibTeX
@article{Banu2026,
author = {Banu, Kauser and Mondal, Bhairab and Kumar, S Madhan and Sudha, C Sai and H, Raju},
title = {A High-Sensitivity Colorimetric Dot-Blot Aptamer Assay Platform for SARS-CoV-2 Nucleocapsid Protein Detection in Resource-Limited Settings},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {7},
pages = {2251--2261},
doi = {10.1021/acsinfecdis.5c01125}
}
EUVIMED